Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2020 3
2021 1
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Conflict of Interest Disclosures.
[No authors listed] [No authors listed] Global Spine J. 2023 May;13(2_suppl):568S-591S. doi: 10.1177/21925682231173597. Global Spine J. 2023. PMID: 37222100 Free PMC article. No abstract available.
A single-oral bolus of 100,000 IU of cholecalciferol at hospital admission did not improve outcomes in the COVID-19 disease: the COVID-VIT-D-a randomised multicentre international clinical trial.
Cannata-Andía JB, Díaz-Sottolano A, Fernández P, Palomo-Antequera C, Herrero-Puente P, Mouzo R, Carrillo-López N, Panizo S, Ibañez GH, Cusumano CA, Ballarino C, Sánchez-Polo V, Pefaur-Penna J, Maderuelo-Riesco I, Calviño-Varela J, Gómez MD, Gómez-Alonso C, Cunningham J, Naves-Díaz M, Douthat W, Fernández-Martín JL; COVID-VIT-D trial collaborators. Cannata-Andía JB, et al. BMC Med. 2022 Feb 18;20(1):83. doi: 10.1186/s12916-022-02290-8. BMC Med. 2022. PMID: 35177066 Free PMC article. Clinical Trial.
P008 Long-Term Effectiveness and Safety of Ustekinumab for The Treatment of Crohn´s Disease: A Brazilian Multicentre Real-world Study.
Rogerio P, Julio C, Liliana C, Erika B, Orlando AJ, Bianca S, Antonio José AJ, Cristina F, Marcio L, Newton G Jr, Mauro B, Matheus A, Adérson D, Natália Q, Flavio S, Nayara C, Sandra B, Eduardo V, Joaquim RJ, Omar F. Rogerio P, et al. Am J Gastroenterol. 2020 Dec 1;115(Suppl 1):S2. doi: 10.14309/01.ajg.0000722828.45880.db. Am J Gastroenterol. 2020. PMID: 33566482 No abstract available.
Anti-TNF therapy for ulcerative colitis in Brazil: a comparative real-world national retrospective multicentric study from the Brazilian study group of IBD (GEDIIB).
Sassaki LY, Magro DO, Saad-Hossne R, Baima JP, Flores C, Correia LM, Celani LMS, De Abreu Ferrari ML, Zacharias P, Feitosa MR, Dos Santos CHM, De Freitas Lins Neto MA, Quaresma AB, De Lima Junior SF, De Vasconcelos GBS, Cassol OS, Dos Santos Pinto A, Kurachi G, Goncalves Filho FA, Gasparini RG, Furlan TK, Catapani WR, Coy CSR, De Souza Menegassi V, Colombo MM, Fróes RSB, Teixeira FV, Moraes AC, Santana GO, Parente JML, Vilela EG, Queiroz NSF, Kotze PG; GEDIIB (Brazilian Study Group of IBD). Sassaki LY, et al. BMC Gastroenterol. 2022 May 29;22(1):268. doi: 10.1186/s12876-022-02341-7. BMC Gastroenterol. 2022. PMID: 35644668 Free PMC article.